China to strengthen global cooperation in trials of Covid-19 vaccine

Published
0

BEIJING: China will strengthen international cooperation in future Covid-19 clinical vaccine trials, building on earlier collaboration in vaccine development, the science and technology minister said on Sunday.

China is expending great efforts in the global scramble to develop a vaccine for the new coronaries epidemic that began in its central city of Wuhan, with Chinese researchers conducting five separate clinical trials on humans, or half of all such trials globally, according to the data compiled by the World Health Organisation.

President Xi Jinping vowed last month at the World Heath Assembly, the WHO’s governing body, that vaccines China’s develops will become a “global public good” once they are ready for use, and it will be China’s contribution to ensuring vaccine accessibility and affordability in developing countries.

Developing “a vaccine is still the fundamental strategy in our effort to overcome the new coronavirus,” Science and Technology Minister Wang Zhigang told a news conference in Beijing.

But vaccine development is very difficult and takes time, he said, when asked how China would initially prioritise shots by country when a vaccine is found.

“The rigour of vaccine development has been compared by some scientists to a dance involving precise steps and rehearsals,” Wang said.

In a white paper unveiled by the State Council Information Office at the news conference, the government urges global cooperation, saying the international community should resist finger-pointing and politicising the virus. It did not name any country.

US President Donald Trump’s administration has accused China of cover-ups and lack of transparency regarding the pandemic. Beijing has repeatedly denied the allegations, saying it has been keeping the world informed from the start.

The head of the Chinese Centre for Disease Control and Prevention briefed his US counterpart by phone on the then-unknown virus as early as Jan 4, according to the white paper.

In the white paper, the Chinese government said the medical cost of all the coronavirus patients in China totalled 1.35 billion yuan ($191 million) as of the end of May.

President Xi last month pledged $2 billion in financial support over the next two years to help deal with Covid-19, especially to help developing countries.

Published in Dawn, June 8th, 2020

Opinion

Editorial

Referendum talk
Updated 14 Nov, 2026

Referendum talk

Unless the PPP is deliberately using Sindh as a bargaining chip, it should issue a clarification with a clear, consistent position on new administrative units, not one tailored to protect its home turf.
Mineral wealth
Updated 14 Nov, 2026

Mineral wealth

Minerals should not be presented as a solution to Pakistan’s long-term economic difficulties. The aim should be to build an industrial base rather than export raw materials.
Late diagnosis
14 Nov, 2026

Late diagnosis

AS we mark World Diabetes Day today, Pakistan faces a troubling question: how many people are living with diabetes...
Climate challenges
Updated 13 Nov, 2026

Climate challenges

Pakistan cannot afford to confront its climate crises one disaster, one season and one international summit at a time.
Under fire
Updated 13 Nov, 2026

Under fire

KP police are increasingly vulnerable as they play a frontline role in ongoing operations against terrorists.
Used car imports
13 Nov, 2026

Used car imports

THE government’s effort to restrict used car imports appears to be faltering. So suggest the numbers. Despite...